Intensified Daunorubicin in Induction Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Postremission Therapy (Double-7 Protocol) for Adult Acute Myeloid Leukemia
スポンサーリンク
概要
- 論文の詳細を見る
- 2002-12-01
著者
-
Yamaguchi Yuko
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
SAITO Takeshi
Division of Oncology and Hematology, Department of Internal Medicine, Jikei University School of Med
-
USUI Noriko
Division of Oncology and Hematology, Department of Internal Medicine, Jikei University School of Med
-
ASAI Osamu
Division of Oncology and Hematology, Department of Internal Medicine, Jikei University School of Med
-
DOBASHI Nobuaki
Division of Oncology and Hematology, Department of Internal Medicine, Jikei University School of Med
-
YANO Shingo
Division of Oncology and Hematology, Department of Internal Medicine, Jikei University School of Med
-
TAKEI Yutaka
Division of Oncology and Hematology, Department of Internal Medicine, Jikei University School of Med
-
OGASAWARA Yoji
Division of Oncology and Hematology, Department of Internal Medicine, Jikei University School of Med
-
YAHAGI Yuichi
Division of Hematology and Oncology, Department of Internal Medicine, Jikei University School of Med
-
SUGIYAMA Katsuki
Division of Hematology and Oncology, Department of Internal Medicine, Jikei University School of Med
-
KASAMA Kinuyo
Division of Hematology and Oncology, Department of Internal Medicine, The Jikei University School of
-
OKAWA Yutaka
Division of Hematology and Oncology, Department of Internal Medicine, The Jikei University School of
-
SEKIGUCHI Naohiro
Division of Hematology and Oncology, Department of Internal Medicine, The Jikei University School of
-
OHTSUBO Hiroko
Division of Hematology and Oncology, Department of Internal Medicine, The Jikei University School of
-
KAITO Ken
Division of Hematology and Oncology, Department of Internal Medicine, The Jikei University School of
-
KOBAYASHI Masayuki
Division of Hematology and Oncology, Department of Internal Medicine, The Jikei University School of
-
Usubuchi Noriko
国立がんセンター中央病院
-
Usubuchi Noriko
Hematology And Oncology Division National Cancer Center Hospital East
-
Sekiguchi Naohiro
Division Of Hematology And Oncology Department Of Internal Medicine The Jikei University School Of M
-
Uike Naokuni
Department Of Hematology National Kyushu Cancer Center Hospital
-
Uike N
National Kyusyu Cancer Center
-
Uoshima Nobuhiko
京都府立医科大学 血液･腫瘍内科学
-
Uoshima Nobuhiko
1st Department Of Internal Medicine Kyoto Prefectureal University Of Medicine
-
Usui Noriko
東京慈恵会医科大学附属病院 中央検査部
-
Usui N
Division Of Hematology And Oncology Department Of Medicine Jikei University
-
Usui Noriko
Jikei University Hospital
-
DOBASHI Nobuaki
Jikei University Hospital
-
Dobashi Nobuaki
東京慈恵会医科大学 内科学(血液･腫瘍)
-
Dobashi Nobuaki
Division Of Hematology And Oncology Department Of Internal Medicine Jikei University School Of Medic
-
Shinagawa K
Okayama Univ. Hospital Okayama Jpn
-
Shinagawa Katsuji
岡山大学 第2内科
-
Usui N
Jikei University Hospital
-
Shinjo Kaori
浜松医科大学 内科学第3
-
Uike Naokuni
Department Of Hemato-oncology Kyushu Cancer Center
-
Kaito K
Central Clinical Laboratory Jikei University Hospital
-
Asai Osamu
Department Of Clinical Oncology And Hematology School Of Medicine The Jikei University
-
Takei Yutaka
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
Okawa Yutaka
Division Of Hematology And Oncology Department Of Internal Medicine The Jikei University School Of M
-
Yahagi Yuichi
Division Of Hematology And Oncology Department Of Internal Medicine Jikei University School Of Medic
-
Kasama Kinuyo
Division Of Hematology And Oncology Department Of Internal Medicine The Jikei University School Of M
-
Otsubo Hiroko
Division Of Hematology And Oncology Department Of Medicine Jikei University
-
Otsubo Hiroko
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
Shimada Takaki
Divesion Of Hematology And Oncology Department Of Internal Medicine Jikei University School Of Medic
-
Ogasawara Yoji
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
Kobayashi M
富山大学 医学薬学研究部腎泌尿器科学
-
Usui Noriko
Division Of Hematology And Oncology Department Of Medicine Jikei University
-
Usui Noriko
Jikei Univ. Hospital Tokyo Jpn
-
Usui Noriko
The "lung Injury By Bortezomib" Joint Committee Of The Japanese Society Of Hematology And
-
Shigeno Kazuyuki
Japan Adult Leukemia Study Group Hamamatsu Jpn
-
Sunami K
Department Of Hematology National Hospital Organization Okayama Medical Center
-
Shinagawa Katsuji
Department Of Biopathological Science Okayama University Graduate School Of Medicine And Dentistry
-
Shinagawa Katsuji
Division Of Hematology/oncology Okayama University Medical School
-
Asai Osamu
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
Dobashi Nobuaki
Jikei Univ. Hospital Tokyo Jpn
-
Sugiyama Katsuki
Division Of Hematology And Oncology Department Of Internal Medicine Jikei University School Of Medic
-
Sugiyama Katsuki
Department Of Medical Oncology Cancer Institute Hospital And Cancer Chemotherapy Center Japanese Fou
-
Sekita Toru
Department Of Internal Medicine (ii) Jikei University School Of Medicine
-
Yano Shingo
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
Usui Noriko
Division Of Oncology & Hematology Department Of Internal Medicine The Jikei University School Of
-
Usui Noriko
Division Of Hematology And Oncology Department Of Internal Medicine Jikei University School Of Medic
-
Ogasawara Yoji
Division Of Clinical Oncology And Hematology Department Of Internal Medicine Jikei University School
-
Yano Shingo
Division Of Clinical Oncology And Hematology Department Of Internal Medicine Jikei University School
-
Sugiyama Katsuki
Division Of Hematology And Oncology Department Of Internal Medicine The Jikei University School Of M
-
Asai Osamu
Division Of Clinical Oncology And Hematology Department Of Internal Medicine Jikei University School
-
Yamaguchi Yuko
Division Of Clinical Oncology And Hematology Department Of Internal Medicine Jikei University School
-
Takei Yutaka
Division Of Clinical Oncology And Hematology Department Of Internal Medicine Jikei University School
-
Saito Takeshi
Division Of Clinical Oncology And Hematology Department Of Internal Medicine Jikei University School
-
Sugiyama Katsuki
Division Of Clinical Oncology And Hematology Department Of Internal Medicine Jikei University School
-
KAITO Ken
Division of Clinical Oncology and Hematology, Department of Internal Medicine, Jikei University School of Medicine
-
DOBASHI Nobuaki
Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine
-
KOBAYASHI Masayuki
Division of Hematology and Oncology, Department of Internal Medicine, Jikei University, School of Medicine
-
SAITO Takeshi
Division of Cardiovascular Surgery, Tohoku University Graduate School of Medicine
関連論文
- Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan : a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
- Elevated serum levels of human matrix metalloproteinase-9 (MMP-9) during the induction of peripheral blood stem cell mobilization by granulocyte colony-stimulating factor (G-CSF)
- Intensifying Daunorubicin in Induction for Patients with Core Binding Factor Leukemia
- Intensified Daunorubicin in Induction Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Postremission Therapy (Double-7 Protocol) for Adult Acute Myeloid Leukemia
- Severe Aplastic Anemia Associated With Chronic Natural Killer Cell Lymphocytosis
- Cardiac Lesions Leading to Sudden Death in a Beagle
- Reconstitution of HLA-A^*2402-Restricted Cytomegalovirus-Specific T-Cells following Stem Cell Transplantation
- G-CSF does not Stimulate Leukemic Stem Cells in Vivo
- Ticlopidine-Associated Thrombotic Thrombocytopenic Purpura With an IgG-Type Inhibitor to von Willebrand Factor-Cleaving Protease Activity
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies
- Allogeneic Peripheral Blood Stem Cell Transplantation in 23 Adult Patients With Hematologic Malignancies: A Single-Center Experience
- Granulocyte Colony-Stimulating Factor and Lineage-Independent Modulation of VLA-4 Expression on Circulating CD34^+ Cells
- Replating potential of colony-forming units of granulocytes/macrophages (CFE-GM) expanded ex vivo by stem cell factor, interleukin (IL)-3, IL-6, granulocyte colony-stimulating factor, erythropoietin with or without thrombopoietin
- Trisomy 12 and t(14;18) in B-cell chronic lymphocytic leukemia
- Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Early cytomegalovirus (CMV) gastrointestinal disease that developed 19 days after bone marrow transplantation, with a high-level of CMV antigenemia, of up to 1120 cells/slide
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
- Phase II Study of Cladribine(2-Chlorodeoxyadenosine) in Relapsed or Refractory Adult T-Cell Leukemia-Lymphoma
- No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
- Case-control study of leukemia and diagnostic radiation exposure
- Therapy-Related Leukemia and Myelodysplastic Syndrome: A Large-scale Japanese Study of Clinical and Cytogenetic Features as Well as Prognostic Factors
- Good Prognosis of Patients With Acute Promyelocytic Leukemia Who Achieved Second Complete Remission (CR) With a New Retinoid, Am80, After Relapse From CR Induced by All-trans-Retionic Acid
- The effect of adding rituximab to CHOP-based therapy on clinical outcomes for Japanese patients with diffuse large B-cell lymphoma : a propensity score matching analysis
- Two Cases of Acute Promyelocytic Leukemia Complicated by Torsade de Pointes during Arsenic Trioxide Therapy
- Two Patients with All-trans Retinoic Acid-Resistant Acute Promyelocytic Leukemia Treated Successfully with Gemtuzumab Ozogamicin as a Single Agent
- Delayed Recovery of Normal Hematopoiesis in Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia: A Comparison to All-trans Retinoic Acid Treatment
- Spicamycin and KRN5500 Induce Apoptosis in Myeloid and Lymphoid Cell Lines with Down-regulation of Bcl-2 Expression and Modulation of Promyelocytic Leukemia Protein
- Relapse in the External Auditory Canal of Acute Promyelocytic Leukemia after Treatment with All-Trans Retinoic Acid
- Allergic Reaction Involving Liver Dysfunction and Disseminated Intravascular Coagulation Caused by a Health Food, Proporis
- New Flow Cytometric Method for Detection of Minimally Expressed Multidrug Resistance P-Glycoprotein on Normal and Acute Leukemia Cells Using Biotinylated MRK16 and Streptavidin-RED670 Conjugate
- Glanzmann Thrombasthenia with Acute Myeloid Leukemia Successfully Treated by Bone Marrow Transplantation
- Morphological Diagnoses of the Japan Adult Leukemia Study Group Acute Myeloid Leukemia Protocols: Central Review
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Expression of Human Tumor-Associated Antigen RCAS1 in Adult T-Cell Leukemia/Lymphoma
- Successful Engraftment of Allogeneic Peripheral Blood Stem Cell Transplant After Nonmyeloablative Preparative Regimen With Cytarabine and Cyclophosphamide: Report of 2 Cases
- Molecular characterization of total kininogen deficiency in Japanese patients
- Analysis of circulating hematopoietic progenitor cells after peripheral blood stem cell transplantation
- Risk of Neutropenic Fever and Early Infectious Complications after Autologous Peripheral Blood Stem Cell Transplantation for Malignant Diseases
- Successful Treatment of Progressive NK Cell Lymphoma with Allogeneic Peripheral Stem Cell Transplantation Followed by Early Cyclosporine Tapering and Donor Leukocyte Infusions
- Ocular Manifestation of Acute Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation
- Severe Bleeding Tendency Caused by Leukemic Infiltration and Destruction of Vascular Walls in Chronic Neutrophilic Leukemia
- Transient Factor VIII Inhibitor in a Hemophilia Patient After Staphylococcal Septic Shock Syndrome
- Multicenter Prospective Study of Interferon α versus Allogeneic Stem Cell Transplantation for Patients with New Diagnoses of Chronic Myelogenous Leukemia
- Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma : Japan Clinical Oncology Group Study (JCOG9109)
- Adult T-Cell Leukemia-Lymphoma Successfully Treated with 2-Chlorodeoxyadenosine
- Combination Chemotherapy With Risk Factor-Adjusted Dose Attenuation for High-Risk Myelodysplastic Syndrome and Resulting Leukemia in the Multicenter Study of the Japan Adult Leukemia Study Group (JALSG): Results of an Interim Analysis
- Successful treatment of cryoglobulinemic glomerulonephritis derived from Waldenstrom's macroglobulinemia by rituximab-CHOP and tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation
- Phase I/II study of tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation for advanced multiple myeloma
- Expression of thyroglobulin on follicular dendritic cells of thyroid mucosa-associated lymphoid tissue (MALT) lymphoma
- Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation
- Calcineurin Inhibitor-Induced Irreversible Neuropathic Pain after Allogeneic Hematopoietic Stem Cell Transplantation
- Myositis as a Manifestation of Chronic Graft-Versus-Host Disease
- Allogeneic Peripheral Blood Stem Cell Transplantation for the Treatment of Refractory Follicular Lymphoma
- Treatment of Refractory Metastatic Choriocarcinoma with Tandem High-Dose Chemotherapy Supported by Peripheral Blood Stem Cell Transplantation : A Case Report
- Graft rejection and recovery of host-derived hematopoiesis after allogeneic bone marrow transplantation : relation to conditioning with high does etoposide and total body irradiation
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- Oncogene Associated cDNA Microarray Analysis Shows PRAME Gene Expression is a Marker for Response to Anthracycline Containing Chemotherapy in Patients with Diffuse Large B-cell Lymphoma
- Pulmonary infiltration with eosinophilia syndrome complicated with non-Hodgkin's lymphoma of B cell lineage
- Peripheral neuropathy caused by high-dose cytosine arabinoside treatment in a patient with acute myeloid leukemia
- Metastasis to the Iris in Squamous Cell Lung Cancer
- High-Dose Etoposide Treatment for CNS Involvement in a Patient with Primary Non-Hodgkin's Lymphoma of the Breast
- Successful Reduced-Intensity Stem Cell Transplantation from an HLA Haploidentical 3-Loci-Mismatched Donor on the Basis of Fetomaternal Microchimerism in a Patient with Advanced Acute Myeloid Leukemia
- The role of Tyk2, Stat1 and Stat4 in LPS-induced endotoxin signals
- Lung Injury Associated with Bortezomib Therapy in Relapsed/Refractory Multiple Myeloma in Japan : A Questionnaire-Based Report from the "Lung Injury by Bortezomib" Joint Committee of the Japanese Society of Hematology and the Japanese Society of Clinical
- Successful Combination Therapy with Trastuzumab and Paclitaxel for Adriamycin- and Docetaxel-Resistant Inflammatory Breast Cancer
- A Novel Mutation in the Juxtamembrane Intracellular Sequence of the Granulocyte Colony-Stimulating Factor (G-CSF) Receptor Gene in a Patient with Severe Congenital Neutropenia Augments G-CSF Proliferation Activity but Not through the MAP Kinase Cascade
- Relationship between morphological classification of the degree of maturation and the ploidy of micromegakaryocytes in myelodysplastic syndrome patients
- Gene Expression of Erythropoietin in Renal Cell Carcinoma
- Carcinoembryonic Antigen-Producing Multiple Myeloma Detected by a Transcription-Reverse Transcription Concerted Reaction System
- Toxicity and Outcome of Intensive Chemotherapy for Acute Lymphoblastic Leukemia Complicated with Turner's Syndrome
- CD2^+ Tetraploid Acute Promyelocytic Leukemia Variant with Double (15 ; 17) Translocations
- Septic Intramuscular Embolism in a Neutropenic Patient with Myelodysplastic Syndrome Accompanied by Asymptomatic Septic Pulmonary Emboli
- Th1/Th2 Lymphocyte Balance in Patients with Aplastic Anemia
- Successful Immunosuppressive Therapy with Cyclosporine A for Posthepatitis B-Cell Deficiency With Activated Cytoplasmic Interferon-γ-Positive T-Lymphocytes
- Renal vein lymphoma embolism in non-Hodgkin lymphoma
- Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era
- Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Efficient Production of Adeno-associated Virus Vectors Using Split-type Helper Plasmids
- Fas and Mutant Estrogen Receptor Chimeric Gene: A Novel Suicide Vector for Tamoxifen-inducible Apoptosis
- Systemic Vasculitis Associated with α1-antitrypsin Deficiency
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Two Cases of Mediastinal Gray Zone Lymphoma
- Bortezomib plus dexamethasone for relapsed or treatment refractory multiple myeloma : the collaborative study at six institutes in Kyoto and Osaka
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies : analysis of eight patients
- Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab : A multicenter phase II study
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Extramedullary Hematopoietic Pleural Effusion Accompanied by Follicular Lymphoma